Easier-to-Access HIV Care for Vulnerable Individuals
Staged Low-Barrier and Mobile Care to Improve Retention and Viral Suppression in Hard-To-Reach Vulnerable People Living With HIV
This project offers flexible, drop-in, and mobile HIV care options for people living with HIV who face challenges like homelessness or substance use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11128693 on NIH RePORTER |
What this research studies
Many existing HIV care systems with fixed appointments don't work well for people facing significant life challenges. This project introduces a new approach with fewer barriers, offering care that can adapt to individual needs. It includes options like drop-in clinics where no appointments are needed, mobile care services that come to you, and the ability to adjust the intensity of care as your situation changes. The goal is to make it much easier for people to stay connected to their HIV treatment and achieve viral suppression.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV who have a high viral load or are off antiretroviral therapy, have struggled with staying in care, and experience homelessness, mental health disorders, or illicit substance use.
Not a fit: Patients who are already consistently engaged in traditional HIV care and have a suppressed viral load may not directly benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this approach could help more people living with HIV stay in care and manage their condition, leading to better health outcomes and reduced transmission.
How similar studies have performed: This intervention builds on evidence-informed components, but its specific multicomponent design and implementation in diverse settings represent a novel approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Christopoulos, Katerina a — University of California, San Francisco
- Study coordinator: Christopoulos, Katerina a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.